MOORE ALISON - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 22, 2023, MOORE ALISON's relationship to Allogene Therapeutics, Inc. (ALLO) is Officer (Chief Technical Officer), and currently has 672,731 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
MOORE ALISON - Insider Non-Derivative Transactions of ALLO Common Stock
MOORE ALISON - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 23, 2023 | Acquisition -- (Common Stock) | 558094 | 0 | 672731 |
| Mar 15, 2023 | F -- (Common Stock) | 8351 | 5.51 | 114637 |